Serum NSE has been widely reported as a tumor marker in diagnosis of brain metastases of small cell lung cancer [27] but not in primary brain tumors, it is possibly because changes in serum NSE levels are sensitive to damages in normal brain tissues caused by tumor compression. This evidence concerns the gene ENO2 and neoplasm.